Ally Therapeutics Revenue
Biotechnology Research • 
Cambridge, Massachusetts, United States • 1-10 Employees
$
Ally Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | $10,000,000 |
Key Contact at Ally Therapeutics
Jessica J. Chiang
Co-Founder, Principal Scientist
Company overview
| Headquarters | 325 Vassar St, Suite, Cambridge, Massachusetts 02139, US |
| Phone number | +13038930552 |
| Website | |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
About Ally Therapeutics
Ally Therapeutics is a new biotech company based in Cambridge, MA dedicated to solving the immune response issues that limit the safety and efficacy of in vivo gene therapies. Backed by ARCH, Alta, and UCB Ventures.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
Ally Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
United Kingdom
Belgium
NetherlandsFrequently asked questions
Ally Therapeutics is located in Cambridge, Massachusetts, US.
You can reach Ally Therapeutics at +13038930552.
Ally Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Ally Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Ally Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.
Ally Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Ally Therapeutics has raised a total of $10,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
